AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| RSH | Respiri Accelerating Activity | 24/04/18 | ||
| RSH | Respiri Limited - Functional Prototype Completed | PRICE SENSITIVE | 20/04/18 | |
| RSH | Respiri Limited - Cleansing Notice | 18/04/18 | ||
| RSH | Respiri Limited $3.0M Share Placement & Appendix 3B | 18/04/18 | ||
| RSH | RESPIRI LIMITED $3.0m SHARE PLACEMENT | PRICE SENSITIVE | 10/04/18 | |
| RSH | Trading Halt Request | 06/04/18 | ||
| RSH | Trading Halt | PRICE SENSITIVE | 06/04/18 | |
| RSH | CEO 100 Day Update | 05/03/18 | ||
| RSH | Half Year Announcement - February 2018 | 26/02/18 | ||
| RSH | Appendix 4D and Interim Financial Report - December 2017 | PRICE SENSITIVE | 26/02/18 | |
| RSH Respiri Accelerating Activity | |||
| 24/04/18 | |||
| RSH Respiri Limited - Functional Prototype Completed | |||
| 20/04/18 | PRICE SENSITIVE | ||
| RSH Respiri Limited - Cleansing Notice | |||
| 18/04/18 | |||
| RSH Respiri Limited $3.0M Share Placement & Appendix 3B | |||
| 18/04/18 | |||
| RSH RESPIRI LIMITED $3.0m SHARE PLACEMENT | |||
| 10/04/18 | PRICE SENSITIVE | ||
| RSH Trading Halt Request | |||
| 06/04/18 | |||
| RSH Trading Halt | |||
| 06/04/18 | PRICE SENSITIVE | ||
| RSH CEO 100 Day Update | |||
| 05/03/18 | |||
| RSH Half Year Announcement - February 2018 | |||
| 26/02/18 | |||
| RSH Appendix 4D and Interim Financial Report - December 2017 | |||
| 26/02/18 | PRICE SENSITIVE | ||
